Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alanex Corp.

Division of Pfizer Inc.

Latest From Alanex Corp.

Safety Razors for the Cutting Edge of Biovogue

The biotech industry's changing fashions--platform technologies, target companies, combinatorial chemistry and positional cloning. One solution: databases.
BioPharmaceutical Strategy

Start-Ups in Biotechnology

For start-ups in biotech, it's the worst and the best of times. On the one hand, new opportunities and new sources of financing. On the other, too many companies and cutthroat competition. Interviews with venture capitalist Lawrence Bock, Peter Drake,PhD, of Vector Securities, and Richard Dimarchi, PhD, vice president of research technology and proteins for Eli Lilly & Co., shed light on current trends.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Marvin A Brown, MD, Pres.
    Michelle A Youngers, Dir. Fin. Operations
    Edgardo Baracchini, PhD, Dir., Bus. Dev. & Strat. Planning
    Alexander Polinsky, PhD, VP, Chemistry & CSO
  • Contact Info
  • Alanex Corp.
    Phone: (619) 455-3200
    3550 General Atomics Court
    San Diego, CA 92121-1194
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register